<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Bodycote Plc — News on 6ix</title>
    <link>https://6ix.com/company/bodycote-plc</link>
    <description>Latest news and press releases for Bodycote Plc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 27 Mar 2026 07:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/bodycote-plc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835e0bb78dffbe2df126209.webp</url>
      <title>Bodycote Plc</title>
      <link>https://6ix.com/company/bodycote-plc</link>
    </image>
    <item>
      <title>Directorate change</title>
      <link>https://6ix.com/company/bodycote-plc/news/directorate-change-736</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/directorate-change-736</guid>
      <pubDate>Fri, 27 Mar 2026 07:00:00 GMT</pubDate>
      <description>Bodycote plc has announced that Cynthia Gordon intends to step down as Non-Executive Director and Chair of the Remuneration Committee, with her departure from the Board expected no later than 26 September 2026. The company is currently undertaking a search to find a replacement for her position.
                Disclaimer*</description>
    </item>
    <item>
      <title>Director/PDMR Shareholding</title>
      <link>https://6ix.com/company/bodycote-plc/news/directorpdmr-shareholding-711</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/directorpdmr-shareholding-711</guid>
      <pubDate>Wed, 25 Mar 2026 13:13:00 GMT</pubDate>
      <description>BODYCOTE PLC announced that Chief Executive Officer Jim Fairbairn and Chief Financial Officer Ben Fidler were granted deferred bonus share awards under the Deferred Bonus Plan. The awards consist of ordinary shares with a nominal value of 17 3/11p each, with a total of 38,224 shares granted at a price of £6.339 per share, with the transaction occurring outside of a trading venue on March 23, 2026.
                Disclaimer*</description>
    </item>
    <item>
      <title>Transaction in Own Shares</title>
      <link>https://6ix.com/company/bodycote-plc/news/transaction-in-own-shares-565</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/transaction-in-own-shares-565</guid>
      <pubDate>Mon, 23 Mar 2026 07:00:00 GMT</pubDate>
      <description>Bodycote plc has purchased 164,567 ordinary shares for cancellation between March 16 and March 20, 2026, as part of its £80 million share repurchase programme, with the highest price paid per share being 673.00 pence and the volume-weighted average price at 641.81 pence. This brings the total shares repurchased since the programme&apos;s commencement to 220,105, leaving 172,542,485 ordinary shares in issue, representing the total voting rights.
                Disclaimer*</description>
    </item>
    <item>
      <title>Launch of new £80 million Share Buyback Progr...</title>
      <link>https://6ix.com/company/bodycote-plc/news/launch-of-new-pound80-million-share-buyback-progr</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/launch-of-new-pound80-million-share-buyback-progr</guid>
      <pubDate>Wed, 11 Mar 2026 07:15:00 GMT</pubDate>
      <description>Bodycote plc has announced a new £80 million share buyback programme, scheduled to conclude by the end of 2027, demonstrating its robust balance sheet and commitment to disciplined capital allocation. This programme will be executed in two tranches, each up to £40 million, with Barclays Bank PLC acting as the purchasing agent. The company has entered into an arrangement with Barclays to acquire up to 12,301,205 ordinary shares before the next Annual General Meeting on May 27, 2026, with further </description>
    </item>
    <item>
      <title>Final Results</title>
      <link>https://6ix.com/company/bodycote-plc/news/final-results-434</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/final-results-434</guid>
      <pubDate>Wed, 11 Mar 2026 07:00:00 GMT</pubDate>
      <description>Bodycote plc reported a 4.0% decrease in revenue to £727.1 million for the full year 2025, with adjusted operating profit falling 11.4% to £114.3 million, impacted by mixed market conditions and a slowdown in Oil &amp; Gas and Automotive sectors, though Aerospace &amp; Defence and Industrial Gas Turbines showed growth. The company maintained its ordinary dividend at 23.0p per share and announced an £80 million share buyback program. For 2026, Bodycote anticipates core organic revenue growth and improved</description>
    </item>
    <item>
      <title>Total Voting Rights</title>
      <link>https://6ix.com/company/bodycote-plc/news/total-voting-rights-273</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/total-voting-rights-273</guid>
      <pubDate>Fri, 27 Feb 2026 15:30:00 GMT</pubDate>
      <description>Bodycote plc announces that as of 27 February 2026, there are 172,762,590 ordinary shares in issue, with no shares held in treasury, resulting in a total of 172,762,590 voting rights. This figure will serve as the denominator for shareholders calculating their notification requirements under the Financial Conduct Authority&apos;s Disclosure and Transparency rules regarding their interests in the company&apos;s share capital.
                Disclaimer*</description>
    </item>
    <item>
      <title>Holding(s) in Company</title>
      <link>https://6ix.com/company/bodycote-plc/news/holdings-in-company-770</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/holdings-in-company-770</guid>
      <pubDate>Fri, 13 Feb 2026 08:00:00 GMT</pubDate>
      <description>The Goldman Sachs Group Inc. has notified BODYCOTE PLC of a change in its major holdings, with the threshold crossed on February 10, 2026. The total voting rights held by Goldman Sachs Asset Management BV, through shares and financial instruments, now stand at 6.769723%, representing 11,695,549 voting rights. This is a decrease from their previous notification where they held 7.978769% of the voting rights. The change is primarily due to a reduction in direct voting rights attached to shares, wh</description>
    </item>
    <item>
      <title>Acquisition Of Spectrum Thermal Processing</title>
      <link>https://6ix.com/company/bodycote-plc/news/acquisition-of-spectrum-thermal-processing</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/acquisition-of-spectrum-thermal-processing</guid>
      <pubDate>Fri, 16 Jan 2026 07:00:00 GMT</pubDate>
      <description>Bodycote plc has acquired Spectrum Thermal Processing, an Aerospace and Defence heat treatment provider in Cranston, Rhode Island, for approximately $8 million in cash. This strategic acquisition enhances Bodycote&apos;s presence in the North American Aerospace &amp; Defence market by adding Nadcap-accredited precision heat treatment capabilities. The move aligns with Bodycote&apos;s strategy to improve its portfolio quality and increase exposure to higher growth markets, following the disposal of ten automot</description>
    </item>
    <item>
      <title>Completion of disposal of ten Non-Core sites ...</title>
      <link>https://6ix.com/company/bodycote-plc/news/completion-of-disposal-of-ten-non-core-sites</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/completion-of-disposal-of-ten-non-core-sites</guid>
      <pubDate>Fri, 21 Nov 2025 07:00:00 GMT</pubDate>
      <description>Bodycote plc has completed the sale of ten non-core sites in France, focused on heat treatment for Automotive and Industrial Markets, to Arcole for €22m in cash. This transaction is a significant step in the Group&apos;s Optimise programme, which is projected to deliver an operating profit benefit of at least £15m by mid-2027, with net programme cash costs estimated between £10m and £15m. The disposal is expected to accelerate Bodycote&apos;s portfolio transformation towards a higher quality, more resilie</description>
    </item>
    <item>
      <title>Divisional re-statement for enhanced Optimise...</title>
      <link>https://6ix.com/company/bodycote-plc/news/divisional-re-statement-for-enhanced-optimise</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/divisional-re-statement-for-enhanced-optimise</guid>
      <pubDate>Tue, 18 Nov 2025 07:05:00 GMT</pubDate>
      <description>Bodycote plc is re-stating historical financial information for 2024 and the first half of 2025 to reflect a new divisional reporting structure, driven by an expanded Optimise programme. This enhanced programme, now encompassing 30 plants and classifying additional sites as Non-Core, is projected to deliver at least £15 million in run-rate profit benefit by mid-2027 for a net cash cost of £10-15 million. For the half year to June 30, 2025, Group revenue was £369.0 million with an adjusted operat</description>
    </item>
    <item>
      <title>November Trading Update</title>
      <link>https://6ix.com/company/bodycote-plc/news/november-trading-update-1</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/november-trading-update-1</guid>
      <pubDate>Tue, 18 Nov 2025 07:00:00 GMT</pubDate>
      <description>Bodycote plc reported improved momentum in its trading update for the four months ending October 31, 2025, with Core organic revenue growing 2.2% year-on-year, narrowing the year-to-date decline to 1.4%. Group organic revenue was broadly stable at +0.3% in the period, with year-to-date revenue at £613m, reflecting Non-Core plant closures. Aerospace &amp; Defence showed strong sequential growth, while Automotive and Industrial markets remained challenging but showed improved year-on-year trends. The </description>
    </item>
    <item>
      <title>Extension of Share Buyback Programme</title>
      <link>https://6ix.com/company/bodycote-plc/news/extension-of-share-buyback-programme-6</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/extension-of-share-buyback-programme-6</guid>
      <pubDate>Wed, 30 Jul 2025 06:15:00 GMT</pubDate>
      <description>Extension of Share Buyback Programme.</description>
    </item>
    <item>
      <title>Bodycote plc - 2025 Interim Results</title>
      <link>https://6ix.com/company/bodycote-plc/news/bodycote-plc-2025-interim-results</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/bodycote-plc-2025-interim-results</guid>
      <pubDate>Wed, 30 Jul 2025 06:00:00 GMT</pubDate>
      <description>Bodycote plc - 2025 Interim Results.</description>
    </item>
    <item>
      <title>Change of Adviser</title>
      <link>https://6ix.com/company/bodycote-plc/news/change-of-adviser-138</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/change-of-adviser-138</guid>
      <pubDate>Fri, 13 Jun 2025 08:00:00 GMT</pubDate>
      <description>Change of Adviser.</description>
    </item>
    <item>
      <title>Post AGM Trading Update</title>
      <link>https://6ix.com/company/bodycote-plc/news/post-agm-trading-update</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/post-agm-trading-update</guid>
      <pubDate>Tue, 27 May 2025 06:00:00 GMT</pubDate>
      <description>Post AGM Trading Update.</description>
    </item>
    <item>
      <title>Result of AGM</title>
      <link>https://6ix.com/company/bodycote-plc/news/result-of-agm-713</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/result-of-agm-713</guid>
      <pubDate>Wed, 21 May 2025 11:48:00 GMT</pubDate>
      <description>Result of AGM.</description>
    </item>
    <item>
      <title>Directorate Change</title>
      <link>https://6ix.com/company/bodycote-plc/news/directorate-change-613</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/directorate-change-613</guid>
      <pubDate>Wed, 21 May 2025 09:31:00 GMT</pubDate>
      <description>Directorate Change.</description>
    </item>
    <item>
      <title>Long-term incentive performance measures and ...</title>
      <link>https://6ix.com/company/bodycote-plc/news/long-term-incentive-performance-measures-and</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/long-term-incentive-performance-measures-and</guid>
      <pubDate>Thu, 17 Apr 2025 14:43:00 GMT</pubDate>
      <description>Long-term incentive performance measures and ....</description>
    </item>
    <item>
      <title>Annual Financial Report</title>
      <link>https://6ix.com/company/bodycote-plc/news/annual-financial-report-313</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/annual-financial-report-313</guid>
      <pubDate>Tue, 15 Apr 2025 08:30:00 GMT</pubDate>
      <description>Annual Financial Report.</description>
    </item>
    <item>
      <title>Director Declaration</title>
      <link>https://6ix.com/company/bodycote-plc/news/director-declaration-318</link>
      <guid isPermaLink="true">https://6ix.com/company/bodycote-plc/news/director-declaration-318</guid>
      <pubDate>Mon, 24 Mar 2025 15:18:00 GMT</pubDate>
      <description>Director Declaration.</description>
    </item>
  </channel>
</rss>